Skip to main content

Judge To Review Viagra, Cialis Bellwether Trial Schedule

Judge To Review Viagra, Cialis Bellwether Trial Schedule

Judge To Review Viagra, Cialis Bellwether Trial Schedule

Introduction

As per a proposed joint agenda submitted on October 9, Judge Richard Seeborg overlooking the Viagra and Cialis multidistrict litigation (MDL No. 2691; In Re: Viagra and Cialis Products Liability Litigation) announced to meet attorneys this week for a case management conference. The conference is planned to review the bellwether trial schedule and provide an update on the litigation status for claims filed by men diagnosed with melanoma skin cancer due to the alleged use of the popular erectile dysfunction drugs.

The conference would also consider a briefing proposal for challenges to the admissibility of the expert witnesses. A series of early bellwether trials are expected to be held for coordinated pretrial proceedings. Ahead of the case management conference, the parties are required to submit an agreed-upon pretrial order which would be used in the completion and execution of Plaintiff Fact Sheets (PFS), along with case specific-discovery and release of plaintiffs' records.

About 865 product liability lawsuits are pending against the manufacturers of these drugs. Each of the lawsuits raises similar allegation that an adequate warning was not sent out to alert consumers about the devastating and life-threatening side- effects of Viagra and Cialis.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.